Jeff Finer is the founder of Septerna. Septerna has raised $100M in total funding. Latest round: Series A. Based in South San Francisco, United States.
Jeffrey Finer, MD, PhD, is the Co-Founder and Chief Executive Officer of Septerna, a biotechnology company launched in January 2022. He previously served as a Board Observer and is associated with Third Rock Ventures. His research forms the basis of Septerna's work on a new drug target in biotechnology.
Full founder directory · Investor directory · Company funding database · Fundraising library